Tegsedi
Payments companies reported to CMS as associated with Tegsedi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tegsedi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tegsedi
These are the largest totals companies reported as associated with Tegsedi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lori Guyton | Herrin, IL | Neurology (Psychiatry & Neurology) | $150.00 |
| David Wolinsky | Weston, FL | Cardiovascular Disease | $150.00 |
| Corey Lum | Las Vegas, NV | Advanced Heart Failure and Transplant Cardiology | $150.00 |
| Todd Christie | Centerville, OH | Physician Assistant | $150.00 |
| William Lievens | Montgomery, AL | Neurology (Psychiatry & Neurology) | $150.00 |
| Marlon Ramilo | Modesto, CA | Cardiovascular Disease | $150.00 |
| Srikanth Muppidi | Stanford, CA | Clinical Neurophysiology | $150.00 |
| Rita Jermyn | Roslyn, NY | Advanced Heart Failure and Transplant Cardiology | $150.00 |
| Nina Kim | New York, NY | Neurology (Psychiatry & Neurology) | $150.00 |
| Thang An | Montgomery, AL | Family Medicine | $150.00 |
Prescribed Tegsedi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.